
Sign up to save your podcasts
Or


Vol. 2, No. 18. The weekly audio edition of MBS Digest. Full issue with every source, free: read Issue 18.
Send us your ideas. Suggest a paper, write a letter or a commentary, share a practice spotlight, propose a poll question, or contribute to Voices of Latin America (Spanish or English): mbs-digest.com/submit. The Editorial Board reviews every promising submission, and disclosures are published with the piece.
Discussed in this episode
Article of the Week: cirrhosis regression after metabolic bariatric surgery in compensated MASH cirrhosis, paired biopsies (Annals of Surgery; biopsy images used with permission from the authors): 10.1097/SLA.0000000000007249
Bariatric surgery as a rescue strategy after semaglutide or tirzepatide (Annals of Surgery): 10.1097/SLA.0000000000007251
Cardiovascular and diabetes outcomes, surgery versus obesity medications (British Journal of Surgery): 10.1093/bjs/znag139
Perioperative outcomes across chronic kidney disease stages (Obesity Surgery; the authors reported no funding): 10.1007/s11695-026-09003-7
Retatrutide for knee osteoarthritis pain and obesity, TRIUMPH-4 (ACR Convergence 2026 abstract, not yet peer reviewed; Lilly-associated authors): ACR abstract
Medicare coverage of Wegovy and Zepbound (Health Affairs Scholar; summarized from the USC Schaeffer report): 10.1093/haschl/qxag299, USC Schaeffer report
Also in this issue (quick hits in the episode)
Long-term exercise and liver fat, meta-analysis (Obesity Reviews): 10.1111/obr.70250
Diet at disease onset and inflammatory memory, in mice (Nature; several authors report drug-company relationships outside this work): 10.1038/s41586-026-11181-4
Science, GLP-1 and Beyond collection: science.org
CMS, CY 2027 Physician Fee Schedule final rule: CMS fact sheet
Andel and Novo employer contribution program (company release): PR Newswire
Read by John D. Scott, MD, FACS. Scripts are drafted with AI assistance from the published issue and reviewed by the host. This is a summary of published evidence, not medical advice.
Hosted on beehiiv. Read the full Privacy Policy at beehiiv.com/privacy.
Vol. 2, No. 17. The weekly audio edition of MBS Digest. Full issue with every source, free: read Issue 17.
Send us your ideas. Suggest a paper, write a commentary, a letter to the editor or a practice spotlight, propose a poll question, or contribute to our new Voices of Latin America section (Spanish or English): mbs-digest.com/submit. The Editorial Board reviews every promising submission, and disclosures are published with the piece.
Discussed in this episode
Article of the Week: ASMBS 2022-2024 procedural volume assessment (Surgery for Obesity and Related Diseases; the authors report relationships with drug and device companies and insurers): 10.1016/j.soard.2026.09.018
Bypass versus sleeve at five years, meta-analysis of four randomized trials (Obesity Surgery): 10.1007/s11695-026-08993-8
Recorded gastroparesis after bypass versus sleeve (Surgery for Obesity and Related Diseases; board member Jerry Dang is a coauthor; coauthor Matthew Kroh reports employment with Medtronic): 10.1016/j.soard.2026.10.003
Dehydration and kidney-injury readmissions after bariatric surgery, MBSAQIP analysis (Surgery; Michael Ujiki reports a Boston Scientific advisory role and fees from WL Gore, Medtronic and Olympus): 10.1016/j.surg.2026.110647
Dopamine in obesity, review (Current Obesity Reports): 10.1007/s13679-026-00763-y
Hugo learning curves in 100 consecutive procedures (Journal of Robotic Surgery): 10.1007/s11701-026-04011-2
Sequential diagnosis with language models (Science; funded by Microsoft, whose employees and shareholders are the authors): 10.1126/science.aeh7930
Ascletis submits an FDA IND for oral amylin agonist ASC39 (company press release): Ascletis release
Also in this issue (quick hits in the episode)
Bariatric surgery and neutrophil extracellular traps, review (Obesity Surgery): 10.1007/s11695-026-08970-1
Baseline insulin sensitivity and the response to weight loss, review (Nature Medicine; one author reports advisory roles with AbbVie and Boehringer Ingelheim and grant support from Merck): 10.1038/s41591-026-04718-7
Childhood obesity, review (JAMA; authors report industry research support and consulting; Sarah Armstrong coauthored the AAP guideline discussed): 10.1001/jama.2026.18806
UK Budget 2026, robotic surgery commitment (government document): HM Treasury Budget 2026
John Morton and Tammy Kindel named SOARD co-editors-in-chief (ASMBS announcement): ASMBS post
Eli Lilly third-quarter 2026 results (company release): Lilly investor release
Read by John D. Scott, MD, FACS. Scripts are drafted with AI assistance from the published issue and reviewed by the host. This is a summary of published evidence, not medical advice.
Hosted on beehiiv. Read the full Privacy Policy at beehiiv.com/privacy.
Dr. Adrian Dan on the future of metabolic and bariatric surgery. In this first guest conversation on The Staple Line, John D. Scott talks with Dr. Adrian Dan about the road from Romania, Algeria and Germany to the American operating room, what moving between four languages taught him about adapting to change, and why he calls this the most successful and the most uncertain moment in the history of metabolic surgery.
In this episode
0:12 Welcome, disclaimer and disclosures
1:50 From Romania to medicine
9:27 Education and the ASMBS
11:05 The most successful and most uncertain moment
17:47 Reinventing the field
23:29 Advice for residents
26:51 Wrap-up
About the guest. Adrian G. Dan, MD, FACS, FASMBS, is Professor of Surgery at Northeast Ohio Medical University (NEOMED) and Medical Director of the Weight Management Institute at Summa Health in Akron, Ohio, where he is also Program Director of the Advanced GI, Minimally Invasive, Foregut and Bariatric Surgery Fellowship. He serves on the Board of Directors of the American Society for Metabolic and Bariatric Surgery (ASMBS).
Disclosures. Dr. Dan is a proctor and instructor for Intuitive Surgical, a shareholder and key opinion leader for Fractyl Health, and the founder and director of National Surgery Review. He took part in his own capacity, not on behalf of Summa Health or any other institution, entity or society. The views expressed are those of the speakers. MBS Digest disclosures: mbs-digest.com/disclosures.
Contact. Dr. Dan can be reached at [email protected] and [email protected].
Send us your ideas. Suggest an article, a commentary, a letter to the editor, or someone we should interview at mbs-digest.com/submit. The Editorial Board reviews every submission.
Hosted by John D. Scott, MD, FACS. Recorded remotely. Edited with AI-assisted tools; nothing was added to or changed in either voice. This conversation is not medical advice.
Hosted on beehiiv. Read the full Privacy Policy at beehiiv.com/privacy.
Vol. 2, No. 16. The weekly audio edition of MBS Digest. Full issue with every source, free: read Issue 16.
Coming Thursday. The Staple Line's first guest interview, with Dr. Adrian Dan of Summa Health, Thursday, October 29, 6:00 AM ET: mbs-digest.com/podcast. Dr. Dan's disclosures: proctor and instructor for Intuitive Surgical; shareholder and key opinion leader for Fractyl Health; founder and director of National Surgery Review. He took part in his own capacity, not on behalf of Summa Health or any other institution, entity or society.
Send us your ideas. Suggest a paper, write a commentary or a letter to the editor, share a practice spotlight or tour, or tell us who you would like interviewed: mbs-digest.com/submit. The Editorial Board reviews every submission, and disclosures are published with the piece.
Discussed in this episode
Retatrutide and obstructive sleep apnea at 80 weeks, two randomized trials (New England Journal of Medicine; funded by Eli Lilly): 10.1056/NEJMoa2611477
Preoperative GERD and 30-day complications, MBSAQIP analysis (Surgery for Obesity and Related Diseases; board member Philip Schauer is a co-author): 10.1016/j.soard.2026.09.010
IFSO position statement on cancer incidence after metabolic bariatric surgery (Obesity Surgery): 10.1007/s11695-026-08966-x
Psychological benefits and harms after bariatric surgery, scoping review (Current Obesity Reports): 10.1007/s13679-026-00768-7
Femoral-neck bone density nine years after sleeve gastrectomy (Obesity Surgery): 10.1007/s11695-026-08957-y
GLP-1 receptor agonist safety, narrative review (Current Obesity Reports): 10.1007/s13679-026-00770-z
GLP-1 therapies and energy intake, systematic review (Obesity Reviews): 10.1111/obr.70245
Obesity-related joint injury after weight loss, review (Current Obesity Reports): 10.1007/s13679-026-00761-0
Obesity coverage microsimulation (Diabetes, Obesity, and Cardiometabolic CARE; several authors work for GlobalData, which consults for obesity-treatment manufacturers, and others are American Diabetes Association employees): 10.2337/doci25-0006
AstraZeneca and insitro collaboration (company press release): AstraZeneca release
Intuitive third-quarter 2026 earnings (company release): Intuitive investor release
Editorial preview: ARMMS-T2D (Diabetes Care, 2026; board member Philip Schauer is a co-author): 10.2337/dc26-1070
Read by John D. Scott, MD, FACS. Scripts are drafted with AI assistance from the published issue and reviewed by the host. This is a summary of published evidence, not medical advice.
Hosted on beehiiv. Read the full Privacy Policy at beehiiv.com/privacy.
Vol. 2, No. 15. The weekly audio edition of MBS Digest. Full issue with every source, free: read Issue 15.
Send us your ideas. Suggest a paper, write a commentary or a letter to the editor, share a practice spotlight, or tell us who you would like to hear interviewed: mbs-digest.com/submit. The Editorial Board reviews every submission, and disclosures are published with the piece.
Discussed in this episode
Bariatric surgery and obesity-related cancer incidence by age and sex (JAMA Surgery): 10.1001/jamasurg.2026.4798
Portomesenteric vein thrombosis after metabolic and bariatric surgery, timing of diagnosis (Surgery for Obesity and Related Diseases; board member Philip Schauer is a co-author): 10.1016/j.soard.2026.10.010
Long-term mortality after bariatric surgery, meta-analysis (Surgery for Obesity and Related Diseases): 10.1016/j.soard.2026.10.009
Adiposity and cancer, systematic review of prospective studies (Nature Metabolism): 10.1038/s42255-026-01542-8
Real-world digital delivery of tirzepatide in women (Nature Medicine; SheMed and eMed employees are co-authors): 10.1038/s41591-026-04687-x
Learning curve of the first 150 Hugo robotic gastric bypass attempts (Journal of Robotic Surgery): 10.1007/s11701-026-04042-9
Revita REMAIN-1 six-month results (sponsor-reported, not peer-reviewed): Fractyl Health release
CHMP positive opinion for orforglipron (Foundayo): European Medicines Agency
Stryker and CMR Surgical alliance: Stryker newsroom
Five-year outcomes of sleeve gastrectomy with transit bipartition in women (Obesity Surgery): 10.1007/s11695-026-08981-y
ASMBS review of AI in metabolic and bariatric surgery (Surgery for Obesity and Related Diseases; revisited at the board's request; board member Jerry Dang is a co-author): 10.1016/j.soard.2026.08.032
Oral VK2735 phase 3 program: Viking Therapeutics release
Zealand Pharma and Generate Biomedicines collaboration: GlobeNewswire release
Also in this issue
Meal timing and ultra-processed food exposure measurement, narrative review (Current Obesity Reports): 10.1007/s13679-026-00765-w
Read by John D. Scott, MD, FACS. Scripts are drafted with AI assistance from the published issue and reviewed by the host. This is a summary of published evidence, not medical advice.
Hosted on beehiiv. Read the full Privacy Policy at beehiiv.com/privacy.
Vol. 2, No. 14. The weekly audio edition of MBS Digest. Full issue with every source, free: read Issue 14.
Discussed in this episode
GLP-1 agonist use and regained weight after bariatric surgery (Obesity): 10.1002/oby.70280
Hindsight 20/20, long-term satisfaction with the decision for surgery (Obesity Surgery): 10.1007/s11695-026-08984-9
Olatorepatide phase 3 LIGHTEN, EASD 2026 (sponsor-reported, not peer-reviewed): Hansoh release
AI segmentation of abdominal wall layers during optical trocar entry (Surgical Endoscopy): 10.1007/s00464-026-13404-1
ASMBS white paper on AI in metabolic and bariatric surgery (Surgery for Obesity and Related Diseases; board member Jerry Dang is a co-author): 10.1016/j.soard.2026.08.032
Magnetic duodeno-ileostomy after sleeve gastrectomy, three-patient series (Obesity Surgery): 10.1007/s11695-026-08973-y
Ascensia and Sava microsensor partnership: Business Wire release
Simulated two-stage versus one-stage SADI-S (Surgery for Obesity and Related Diseases): 10.1016/j.soard.2026.09.025
GDF15 and weight loss after sleeve gastrectomy (Surgical Endoscopy): 10.1007/s00464-026-13491-0
Also in this issue
CBL-514, phase 2 subgroup, EASD 2026 abstract: Science Media Centre expert reaction
SLC25A34 and adipocyte lipid cycling (Science): 10.1126/science.adz4797
Read by John D. Scott, MD, FACS. Scripts are drafted with AI assistance from the published issue and reviewed by the host. This is a summary of published evidence, not medical advice.
Hosted on beehiiv. Read the full Privacy Policy at beehiiv.com/privacy.
The Staple Line is the weekly audio edition of MBS Digest, the newsletter for metabolic and bariatric surgery.
Every Wednesday: ten minutes on the papers and stories our editorial board voted to the top of the week, across surgery research, the science of obesity and metabolism, innovation and technology, and the marketplace.
Read by John D. Scott, MD, FACS. The host drafts scripts from the published issue and reviews them. This is a summary of published evidence, not medical advice.
Get the full issue with sources, free: mbs-digest.com
Hosted on beehiiv. Read the full Privacy Policy at beehiiv.com/privacy.
From the publisher's feed